Lexology November 28, 2022
How will pharma use health data for clinical trials in the future? The power of clinical trial tokenisation
On 25 October 2022 leading researchers and executives from some of the world’s pioneering drug and pharmaceutical companies came together at a Financial Times Live Webinar event to discuss “The Power of Clinical Trial Tokenisation”.
Tokenisation of healthcare data is likely to be one of the next great innovations for developing life-saving drugs and treatments through the method of privacy preserving record linkage (PPRL). This allows pharmaceutical companies to ‘tokenise’ and link previously scattered patient datasets to produce unique insights. We’ve set out top 5 takeaways on tokenisation from the webinar below:
- How does it work? The digital token creates a...